Dr. John David Swanson Iv, MD Preventive Medicine - Occupational Medicine Medicare: Accepting Medicare Assignments Practice Location: 750 N Syringa St Ste 100, Post Falls, ID 83854 Phone: 208-262-2600 Fax: 208-262-2700 |
Dr. Kirk Hjeltness, MD Preventive Medicine - Occupational Medicine Medicare: Accepting Medicare Assignments Practice Location: 750 N Syringa St Ste 100, Post Falls, ID 83854 Phone: 208-262-2600 Fax: 208-262-2700 |
Paul Creighton, Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 5038 E River Pl, Post Falls, ID 83854 Phone: 208-680-8296 |
News Archive
By combining local radiation therapy and anti-cancer vaccines with checkpoint inhibitors, researchers from the University of Chicago, working with mice, were able to increase the response rate for these new immunotherapy agents.
New research shows mortality rates are two times higher in postmenopausal women with rheumatoid arthritis (RA) and anti-cyclic citrullinated peptide (anti-CCP) antibodies. Findings published in the American College of Rheumatology (ACR) journal Arthritis & Rheumatism, soon to be called Arthritis & Rheumatology, indicate the higher mortality rates persisted after adjusting for age, positive rheumatoid factor, positive antinuclear antibodies (ANA) and disease modifying anti-rheumatic drug (DMARD) use.
NTNU Professors May-Britt and Edvard Moser have been selected for the 2011 Anders Jahre's Award for Medical Research. The award, which includes a NOK 1 million (€128,000) prize, is considered among the most prestigious of medical awards in the Nordic countries.
Now, a team of researchers at the University of Southern California (USC) has revealed the order of symptoms often experienced by those who infected with SARS-CoV-2. Knowing the order of the symptoms may help the patients seek medical help immediately. The research is published in the journal Frontiers in Public Health.
Imaging with the molecular imaging tracer 18F-FDOPA can help distinguish radiation-induced lesions from new tumor growth in patients who have been treated with radiation for brain metastases, according to new research published in The Journal of Nuclear Medicine. Using this amino acid tracer, researchers found that physicians could accurately differentiate the two types of lesions 83 percent of the time. Progression-free survival could also be predicted through evaluating the 18F-FDOPA imaging results.
› Verified 3 days ago